Andrade, G. M. (2026) “Capivasertib and fulvestrant, a new salvation for hormone receptor-positive breast cancer? A systematic review”, Mastology. Rio de Janeiro, 34(suppl. 1). doi: 10.29289/259453942024V34S1039.